These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6505626)

  • 1. Range and clinical significance of the number of myeloid-committed stem cells in the blood of patients with acute leukaemia in remission.
    Hinterberger W; Bettelheim P; Höcker P; Lechner K; Neumann E; Niessner H
    Scand J Haematol; 1984 Sep; 33(3):244-51. PubMed ID: 6505626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
    Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
    Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
    Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
    Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFU-mix are no better than CFU-GM in predicting hemopoietic reconstitutive capacity of peripheral blood stem cells collected in the very early remission phase of acute nonlymphoblastic leukemia.
    To LB; Dyson PG; Branford AL; Haylock DN; Kimber RJ; Juttner CA
    Exp Hematol; 1987 May; 15(4):351-4. PubMed ID: 2883016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the S-phase fraction of myeloid-determined stem cells (CFU-GM) using the cytosine arabinoside suicide technic in patients with acute myeloid leukemia in complete remission following polychemotherapy].
    Goldschmidt H; Elstner E; Wulsche H; Wächter M; Ihle R
    Arch Geschwulstforsch; 1987; 57(5):385-92. PubMed ID: 3479950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colony formation of CFU-MK and other hemopoietic progenitors in patients with acute non-lymphoblastic leukemia at diagnosis and following complete remission.
    Chen Y; Li P; Lin B; Zhang G; Ruan C
    Nouv Rev Fr Hematol (1978); 1989; 31(3):183-6. PubMed ID: 2616265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFU-gm colony formation of peripheral blood and bone marrow in adult acute leukemia at presentation, during remission, and at relapse.
    Jehn U; Wachholz K
    Int J Cell Cloning; 1985 Jul; 3(4):199-213. PubMed ID: 3860564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between blood granulocyte progenitor cells and polymorphonuclear leukocytes. A tentative pathophysiological subgrouping of neutropenic and neutrophilic patients.
    Ponassi A; Morra L; Mela GS; Caristo G; Parodi GB; Sacchetti C
    Biomed Pharmacother; 1983; 37(6):293-7. PubMed ID: 6671134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro proliferation of hematopoietic stem cells circulating in blood of patients with kidney allografts.
    Górski A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):969-73. PubMed ID: 373694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y; Harada M; Teshima T; Makino S; Inaba S; Akashi K; Shibuya T; Niho Y
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collection of circulating stem cells and their use for autograft in adults with acute lymphoblastic leukaemia.
    Hénon P; Debecker A; Lepers M; Eisenmann JC; Kandel G; Dorr R; Selva J
    Nouv Rev Fr Hematol (1978); 1988; 30(4):229-35. PubMed ID: 3057436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY; Marley SB; Lewis JL; Davidson RJ; Nguyen DX; Grand FH; Amos TA; Goldman JM
    J Clin Invest; 1998 Aug; 102(4):710-5. PubMed ID: 9710439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating colony-forming cells in different stages of chronic myelocytic leukemia.
    Leong SS; Sokal JE; Gomez GA; Horoszewicz JS
    Cancer Res; 1979 Jul; 39(7 Pt 1):2704-10. PubMed ID: 286638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.